Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 116 results for anticoagulation

  1. Screening secondary care patients for atrial fibrillation: The SOS-AF service

    CHA2DS2-VASc assessment tool and consider the risks and benefits of anticoagulation. Where appropriate, treatment is started before...

  2. Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (DG14)

    Evidence-based recommendations on the CoaguChek XS system for self-monitoring coagulation status in adults and children. The recommendations originally included the InRatio2 PT/INR, but this was withdrawn from the market in October 2016 and is not currently available

  3. Myocardial infarction: dual antiplatelets (IND76)

    This indicator covers the proportion of patients with acute myocardial infarction who were discharged on dual antiplatelet therapy. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG95

  4. Anticoagulation and antiplatelet therapy: In adults with biological valve replacement, what effect does anticoagulation or antiplatelet therapy have on long-term valve function and outcomes?

    Question Anticoagulation and antiplatelet therapy: In adults with biological valve replacement, what effect does...

  5. Improving patients time in range on warfarin

    aimed to safely manage patients according to NICE guidelines regarding anticoagulation. Patients on warfarin need tight control over...

  6. Atrial Fibrillation (AF) Holistic Care Pathway

    practice were chosen and incorporated locally. Examples include: Anticoagulation assessment with better uptake of DOAC. Address...

  7. Implementing point-of-care D-dimer tests for deep vein thrombosis (DVT)

    states that if a D-dimer test cannot be obtained within 4 hours, interim anticoagulation should be given. If a person has a low...

  8. Improving the care of patients discharged following a pulmonary embolism, in line with NICE Guidelines (NG158)

    about 2–8% in the 3 months following diagnosis. The benefit of early anticoagulation to improve mortality and decrease recurrent...

  9. Acute upper gastrointestinal bleeding in over 16s: management (CG141)

    This guideline covers how upper gastrointestinal bleeding can be effectively managed in adults and young people aged 16 years and older. It aims to identify which diagnostic and therapeutic steps are useful so hospitals can develop a structure in which clinical teams can deliver an optimum service for people who develop this condition.

  10. Insights from the NHS: the adoption of self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor) for atrial fibrillation and heart valve disease

    Health Call INR service, was developed by the clinicians working in the anticoagulation clinic and the chief pharmacist. This ensured...

  11. Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA275)

    Evidence-based recommendations on apixaban (Eliquis) for preventing stroke and systemic embolism in adults with non-valvular atrial fibrillation.

  12. Safe and effective management of stroke prevention in atrial fibrillation

    comprises of anticoagulants, with clear evidence to support the fact that anticoagulation with vitamin K antagonists (VKAs) or direct...

  13. GreenLight XPS for treating benign prostatic hyperplasia (MTG74)

    Evidence-based recommendations on GreenLight XPS for benign prostatic hyperplasia.

  14. Accelerated Implantable Cardiac Monitor (ICM) insertion for the detection of Atrial Fibrillation in Cryptogenic Stroke

    performed remotely by the cardiac physiology team. If AF was detected, anticoagulation therapy was initiated without delay by the nurse...

  15. Aortic valve reconstruction with processed bovine pericardium (IPG604)

    Evidence-based recommendations on aortic valve reconstruction with processed bovine pericardium. This involves replacing a damaged aortic valve with a new valve made from chemically treated cow pericardium.